106 related articles for article (PubMed ID: 12033641)
1. Improved performance of ELISAs for fertility assessment using common reagents and assay protocol as evidence from quality control studies.
Desai MP; Donde UM; Khatkhatay MI
J Immunoassay Immunochem; 2002; 23(2):163-80. PubMed ID: 12033641
[TBL] [Abstract][Full Text] [Related]
2. The development of over-the-counter (OTC) assays for pregnanediol-3-glucuronide and estrone-B,D-glucuronide.
Bahar I
Prog Clin Biol Res; 1988; 285():139-51. PubMed ID: 3231643
[TBL] [Abstract][Full Text] [Related]
3. The OVEIA Dual Analyte assay--a new method for profiling the menstrual cycle.
Baker TS
Prog Clin Biol Res; 1988; 285():101-18. PubMed ID: 3231642
[TBL] [Abstract][Full Text] [Related]
4. Power analyses and immunoassays for measuring reproductive hormones in urine to assess female reproductive potential in field studies.
Kesner JS; Krieg EF; Knecht EA; Wright DM
Scand J Work Environ Health; 1992; 18 Suppl 2():33-6. PubMed ID: 1514079
[No Abstract] [Full Text] [Related]
5. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
[TBL] [Abstract][Full Text] [Related]
6. Assessment of assay sensitivity and precision in a malaria antibody ELISA.
Rajasekariah GH; Kay GE; Russell NV; Smithyman AM
J Immunoassay Immunochem; 2003; 24(1):89-112. PubMed ID: 12680609
[TBL] [Abstract][Full Text] [Related]
7. Excretory profile of inhibin-like peptide (ILP) during human menstrual cycle: a probable marker for determination of fertile period.
Khatkhatay I; Desai MP; Sheth AR
Eur J Obstet Gynecol Reprod Biol; 1994 Jun; 55(2):117-21. PubMed ID: 7958149
[TBL] [Abstract][Full Text] [Related]
8. Prediction of ovulation with the assessment of LH and the E1G/P2G ratio in urinary samples.
Baviera G; Carroccio G; Scurria L; Pizzi V; Scarselli G
Acta Eur Fertil; 1988; 19(3):139-42. PubMed ID: 3067480
[TBL] [Abstract][Full Text] [Related]
9. Mean versus individual hormonal profiles in the menstrual cycle.
Alliende ME
Fertil Steril; 2002 Jul; 78(1):90-5. PubMed ID: 12095496
[TBL] [Abstract][Full Text] [Related]
10. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
11. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
Adekunle AO; Collins WP; Whitehead MI
Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
[TBL] [Abstract][Full Text] [Related]
12. Enhanced follicle regulatory protein levels accompany reinitiation of ovulatory function after parturition.
Albertson BD; Rodgers KE; Tomai TP; Nolan-Watson K; Zinaman MJ; DiZerega GS
Am J Obstet Gynecol; 1992 Jul; 167(1):158-62. PubMed ID: 1442919
[TBL] [Abstract][Full Text] [Related]
13. Improved performance of plasma gonadotrophin assays using common reagents and assay protocols: evidence from the UK External Quality Assessment Scheme.
Hayes M; Ferguson KM; Jeffcoate SL; Bacon RR; Seth J
Ann Clin Biochem; 1985 Mar; 22 ( Pt 2)():179-84. PubMed ID: 3923896
[TBL] [Abstract][Full Text] [Related]
14. Characterizing daily urinary hormone profiles for women at midlife using functional data analysis.
Meyer PM; Zeger SL; Harlow SD; Sowers M; Crawford S; Luborsky JL; Janssen I; McConnell DS; Randolph JF; Weiss G
Am J Epidemiol; 2007 Apr; 165(8):936-45. PubMed ID: 17267418
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the urinary luteinizing hormone surge in young ovulatory women.
Park SJ; Goldsmith LT; Skurnick JH; Wojtczuk A; Weiss G
Fertil Steril; 2007 Sep; 88(3):684-90. PubMed ID: 17434509
[TBL] [Abstract][Full Text] [Related]
16. Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles.
Johnson L; Sammel MD; Schanne A; Lechtenberg L; Prewitt M; Gracia C
Fertil Steril; 2016 Dec; 106(7):1793-1799.e2. PubMed ID: 27666565
[TBL] [Abstract][Full Text] [Related]
17. Predicting menstrual migraine with a home-use fertility monitor.
MacGregor EA; Frith A; Ellis J; Aspinall L
Neurology; 2005 Feb; 64(3):561-3. PubMed ID: 15699399
[TBL] [Abstract][Full Text] [Related]
18. Urinary estrone glucuronide, pregnanediol glucuronide and human chorionic gonadotrophin in threatened abortion.
Ishwad PC; Chitlange SM; Joshi UM; Chowdhury V; Mehta AC
Int J Gynaecol Obstet; 1988 Aug; 27(1):107-11. PubMed ID: 2905284
[TBL] [Abstract][Full Text] [Related]
19. Single- and multi-analyte determination of gonadotropic hormones in urine by Surface Plasmon Resonance immunoassay.
Treviño J; Calle A; Rodríguez-Frade JM; Mellado M; Lechuga LM
Anal Chim Acta; 2009 Aug; 647(2):202-9. PubMed ID: 19591706
[TBL] [Abstract][Full Text] [Related]
20. Determination of ovarian function using first morning urine steroid assays.
Denari JH; Farinati Z; Casas PR; Oliva A
Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
